S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

OVV Ovintiv Inc

44.13

0.86 (1.99%)

Feb 14 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

0000950170-24-054736.txt

Ovintiv (NYSE:OVV)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Ovintiv Charts.

Ovintiv (NYSE:OVV)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Ovintiv Charts.

Ovintiv Inc News

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 5 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Tuesday 4 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 31 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 31 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Ovintiv Announces Closing of Montney Asset Acquisition
Friday 31 January 2025 (2 weeks ago) • PR Newswire (US)

Form 8-K - Current report
Monday 27 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Ovintiv Names Terri King to Board of Directors
Monday 27 January 2025 (3 weeks ago) • PR Newswire (Canada)

Form 8-K - Current report
Wednesday 22 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Ovintiv Announces Closing of Uinta Asset Sale
Wednesday 22 January 2025 (4 weeks ago) • PR Newswire (US)

Ovintiv to Host its 2024 Fourth Quarter and Year-End Results Conference Call and Webcast on February 27, 2025
Thursday 16 January 2025 (1 month ago) • PR Newswire (Canada)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 2 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 2 January 2025 (1 month ago) • Edgar (US Regulatory)

More Ovintiv Inc News Articles

Elite Pharmaceuticals (QB)

Fannie Mae (QB)

Lightwave Logic

Anavex Life Sciences

Good Vibrations Shoes (PK)

Northwest Biotherapeutics (QB)

North Bay Resources (PK)

Rennova Health (CE)

Kraig Biocraft Laborator... (QB)

Accredited Solutions (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions